Sphera Funds Management Ltd. Sarepta Therapeutics, Inc. Call Options Transaction History

Sphera Funds Management Ltd.

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $1.74 Million - $2.19 Million	-14,000 Reduced 93.33%	1,000 $124,000
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $1.7 Million - $2.46 Million	15,000 New	15,000 $2.37 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $1.78 Million - $3.29 Million	26,400 New	26,400 $2.55 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $8.33 Million - $12.3 Million	78,300 New	78,300 $8.97 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $26.7 Million - $62.5 Million	-370,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $27.6 Million - $39.3 Million	220,000 Added 146.67%	370,000 $63.1 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $3.81 Million - $5.17 Million	30,000 Added 25.0%	150,000 $21.1 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $3.37 Million - $4.56 Million	-30,000 Reduced 20.0%	120,000 $0
Q3 2017 Nov 09, 2017	BUY	$35.73 - $47.15 $5.36 Million - $7.07 Million	150,000	150,000 $6.8 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.